Home / Researchers / Online Application / IRBWise Help / Consent Procedures

Proposed Consent Procedures

WHY THIS INFORMATION IS IMPORTANT TO THE IRB:

If the study plans to enroll research participants who do not understand the English language, then it is imperative that all subjects have an opportunity to understand enough about the study and the elements of consent in order to make an informed decision about participating in a research study. This means the consent must be translated and presented to the prospective participant in the language the non-English speaking participant understands. If you anticipate enrolling non-English speaking participants, the written consent form should be translated to the appropriate language. Alternatively, if approved by the IRB, an oral consent procedure using a short form presented in the relevant language by a person who is fluent in both English and the relevant language may be used.

If the population involves non-English-speaking participants, a translated version of the consent is required, unless the DOH IRB has approved an alteration or waiver of consent. The DOH IRB does not provide translation services. However, investigators may wait to have the consent translated until the English version is approved by the IRB.

INVESTIGATOR HELP:

Regulations allow for a translated written informed consent document or a written short form consent document with an oral presentation in a language understandable to the participant. It is best to have the IRB approved English version of the consent form translated to avoid multiple translations resulting from IRB requested changes.

Department of Health and Human Services regulations require that informed consent information be presented "in language understandable to the subject" and, in most situations, that informed consent be documented in writing.

The written consent document should include, in language understandable to the subject, all the elements necessary for legally effective informed consent. Subjects who do not speak English should be presented with a consent document written in a language understandable to them. OHRP strongly encourages the use of this procedure whenever possible.

Regulations permit oral presentation of informed consent information in conjunction with a short form written consent document (stating that the elements of consent have been presented orally) and a written summary of what is presented orally. A witness to the oral presentation is required, and the subject must be given copies of the short form document and the summary.

When this procedure is used with subjects who do not speak English, (i) the oral presentation and the short form written document should be in a language understandable to the subject; (ii) the IRB-approved English language informed consent document may serve as the summary; and (iii) the witness should be fluent in both English and the language of the subject.

At the time of consent, (i) the short form document should be signed by the subject (or the subject's legally authorized representative); (ii) the summary (i.e., the English language informed consent document) should be signed by the person obtaining consent as authorized under the protocol; and (iii) the short form document and the summary should be signed by the witness. When the person obtaining consent is assisted by a translator, the translator may serve as the witness.

The IRB must receive all foreign language versions of the short form document as a condition of approval. Expedited review of these versions is acceptable if the protocol, the full English language informed consent document, and the English version of the short form document have already been approved by the convened IRB.

It is the responsibility of the IRB to determine which of the procedures is appropriate for documenting informed consent in protocols that it reviews.

IRB POLICIES AND PROCEDURES:

IRB Policy IV.B - Documentation of Informed Consent for Human Subjects Research

It is the policy of the DOH IRB that informed consent is documented in writing as determined in the IRB review and approval process.

FEDERAL REGULATIONS/GUIDANCE:

Title 45 Code of Federal Regulations Part 46
§46.117 Documentation of informed consent.

(a) Except as provided in paragraph (c) of this section, informed consent shall be documented by the use of a written consent form approved by the IRB and signed by the subject or the subject's legally authorized representative. A copy shall be given to the person signing the form.

(b) Except as provided in paragraph (c) of this section, the consent form may be either of the following:

(1) A written consent document that embodies the elements of informed consent required by §46.116. This form may be read to the subject or the subject's legally authorized representative, but in any event, the investigator shall give either the subject or the representative adequate opportunity to read it before it is signed; or

(2) A short form written consent document stating that the elements of informed consent required by §46.116 have been presented orally to the subject or the subject's legally authorized representative. When this method is used, there shall be a witness to the oral presentation. Also, the IRB shall approve a written summary of what is to be said to the subject or the representative. Only the short form itself is to be signed by the subject or the representative. However, the witness shall sign both the short form and a copy of the summary, and the person actually obtaining consent shall sign a copy of the summary. A copy of the summary shall be given to the subject or the representative, in addition to a copy of the short form.

(c) An IRB may waive the requirement for the investigator to obtain a signed consent form for some or all subjects if it finds either:

(1) That the only record linking the subject and the research would be the consent document and the principal risk would be potential harm resulting from a breach of confidentiality. Each subject will be asked whether the subject wants documentation linking the subject with the research, and the subject's wishes will govern; or

(2) That the research presents no more than minimal risk of harm to subjects and involves no procedures for which written consent is normally required outside of the research context.

In cases in which the documentation requirement is waived, the IRB may require the investigator to provide subjects with a written statement regarding the research.